Cold Urticaria
📧 Sign up to get email alerts when something new happens for Cold Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD) [Phase 3]
Phase 3 study (EMBARQ - ColdU and SD) evaluating barzolvolimab versus placebo for cold-induced urticaria and symptomatic dermographism in ad…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases [Phase 1]
A single-dose, Phase 1 study of YH35324 in patients with allergic diseases, including chronic spontaneous urticaria and chronic inducible ur…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria [Phase 1]
A Phase 1 study evaluating the mechanism of action of Ligelizumab (QGE031) in patients with chronic urticaria has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Cold Urticaria Treatment With Xolair [Phase 2]
Phase 2 study evaluating omalizumab (Xolair) for cold urticaria has completed. Results were posted in February 2016.
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria [Phase 4]
A Phase 4 trial evaluated desloratadine at 5, 10, and 20 mg in patients with cold urticaria; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.